BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 16880939)

  • 21. The chemical hunt for the identification of drugable targets.
    Meisner NC; Hintersteiner M; Uhl V; Weidemann T; Schmied M; Gstach H; Auer M
    Curr Opin Chem Biol; 2004 Aug; 8(4):424-31. PubMed ID: 15338571
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The principle of complementarity: chemical versus biological space.
    Haggarty SJ
    Curr Opin Chem Biol; 2005 Jun; 9(3):296-303. PubMed ID: 15939332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Strategies and tactics for optimizing the Hit-to-Lead process and beyond--a computational chemistry perspective.
    Manly CJ; Chandrasekhar J; Ochterski JW; Hammer JD; Warfield BB
    Drug Discov Today; 2008 Feb; 13(3-4):99-109. PubMed ID: 18275907
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A pipeline for ligand discovery using small-molecule microarrays.
    Duffner JL; Clemons PA; Koehler AN
    Curr Opin Chem Biol; 2007 Feb; 11(1):74-82. PubMed ID: 17169601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genomic filtering: an approach to discovering novel antiparasitics.
    McCarter JP
    Trends Parasitol; 2004 Oct; 20(10):462-8. PubMed ID: 15363439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assay Related Target Similarity (ARTS) - chemogenomics approach for quantitative comparison of biological targets.
    Bieler M; Heilker R; Köppen H; Schneider G
    J Chem Inf Model; 2011 Aug; 51(8):1897-905. PubMed ID: 21761911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Drug discovery based on genomic information].
    Nohmi T
    Rinsho Byori; 2002 Jul; 50(7):694-7. PubMed ID: 12187707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cell biology, chemogenomics and chemoproteomics.
    Gagna CE; Winokur D; Clark Lambert W
    Cell Biol Int; 2004; 28(11):755-64. PubMed ID: 15563397
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of diversity and focused combinatorial libraries in drug discovery.
    Young SS; Ge N
    Curr Opin Drug Discov Devel; 2004 May; 7(3):318-24. PubMed ID: 15216935
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemical complementation: a definitive phenotypic strategy for identifying small molecule inhibitors of elusive cellular targets.
    Vogt A; Lazo JS
    Pharmacol Ther; 2005 Aug; 107(2):212-21. PubMed ID: 15925410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Computational chemogenomics approaches to systematic knowledge-based drug discovery.
    Mestres J
    Curr Opin Drug Discov Devel; 2004 May; 7(3):304-13. PubMed ID: 15216933
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Informatics and modeling challenges in fragment-based drug discovery.
    Hubbard RE; Chen I; Davis B
    Curr Opin Drug Discov Devel; 2007 May; 10(3):289-97. PubMed ID: 17554855
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational chemistry approaches to drug discovery in signal transduction.
    Fischer PM
    Biotechnol J; 2008 Apr; 3(4):452-70. PubMed ID: 18412174
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Application of combinatorial chemistry science on modern drug discovery.
    Kennedy JP; Williams L; Bridges TM; Daniels RN; Weaver D; Lindsley CW
    J Comb Chem; 2008; 10(3):345-54. PubMed ID: 18220367
    [No Abstract]   [Full Text] [Related]  

  • 36. Chemogenomic strategies to expand the bioactive chemical space.
    Jacoby E; Mozzarelli A
    Curr Med Chem; 2009; 16(33):4374-81. PubMed ID: 19835567
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The impact of combinatorial chemistry on drug discovery.
    Lee A; Breitenbucher JG
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):494-508. PubMed ID: 12951813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Seeing small molecules in action with bioorthogonal chemistry.
    Raghavan AS; Hang HC
    Drug Discov Today; 2009 Feb; 14(3-4):178-84. PubMed ID: 18973827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Computational analysis of ligand relationships within target families.
    Bajorath J
    Curr Opin Chem Biol; 2008 Jun; 12(3):352-8. PubMed ID: 18312862
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Compound library design for target families.
    Balakin KV; Ivanenkov YA; Savchuk NP
    Methods Mol Biol; 2009; 575():21-46. PubMed ID: 19727610
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.